Institution
National Jewish Health
Also known as: National Jewish Medical and Research Center
- 67running trials
- 35closed trials
- 18,204publications (OpenAlex)
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Recruiting
Recruiting
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Recruiting
Recruiting
Study With Phage for CF Subjects With Pseudomonas Lung Infection
Active, not recruiting
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
Active, not recruiting
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Recruiting
Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
Recruiting
Recruiting
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Recruiting
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Recruiting
Recruiting
Recruiting
Enhancing Hypnotic Medication Discontinuation in Primary Care
Active, not recruiting
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Active, not recruiting
A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases
Active, not recruiting
Recruiting
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Not yet recruiting
Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma
Recruiting
Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia
Enrolling by invitation
Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation
Enrolling by invitation
Prospective Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria
Active, not recruiting
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy
Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease
Active, not recruiting
Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)
Active, not recruiting
Prospective Study of Pregnancy in Women With Cystic Fibrosis
Recruiting
Active, not recruiting
Recruiting
IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
Showing 50 of 67.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Cystic fibrosis15 recruiting
- Asthma4 recruiting
- COPD4 recruiting
- High blood pressure4 recruiting
- Insomnia3 recruiting
- Pulmonary arterial hypertension3 recruiting
- Idiopathic pulmonary fibrosis2 recruiting
- ANCA-associated vasculitis1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Bronchiectasis1 recruiting
- Hearing loss1 recruiting
- Tuberculosis1 recruiting
Closed trials
Completed
Completed
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)
Recruiting
Terminated
Terminated
Completed
A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis
Completed
Completed
Completed
Completed
Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema
Completed
Completed
Completed
Completed
A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
Completed
Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis
Completed
Completed
Completed
Completed
Completed
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Completed
DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)
Completed
Completed
Completed
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study
Completed
Medication Adherence With Telehealthcare Medication Therapy Management
Completed
Real World and Genomic Data Based Asthma Insight Through Network Analysis
Completed
Completed
Completed
Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency
Completed
Completed
Completed
Completed
Completed
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Recruiting
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Registry name variants (6)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
National Jewish Health
Denver, Colorado 80206
92 trials
National Jewish Medical and Research Center
Denver, Colorado 80206
5 trials
National Jewish Health: Division of Pediatric Allergy and Clinical Immunology
Denver, Colorado 80206
2 trials
NCT06504160Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Contact: Tyler Swenson
NCT05436535Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis
National Jewish Medical and Research Center- Site Number : 123
Denver, Colorado 80206-2761
2 trials
Division of Pediatric Allergy and Clinical Immunology, National Jewish Health
Denver, Colorado 80206
1 trial
NCT03742414Seal, Stopping Eczema and Allergy Study
National Jewish Health, University of Colorado
Denver, Colorado 80206
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Asthma129 works · 12 trials
- Cystic fibrosis75 works · 33 trials
- COPD53 works · 8 trials
- Idiopathic pulmonary fibrosis40 works · 10 trials
- Atopic dermatitis (eczema)39 works · 5 trials
- Bronchiectasis33 works · 4 trials
- Pulmonary arterial hypertension17 works · 6 trials
- Sarcoidosis17 works · 1 trial
- Chronic rhinosinusitis with nasal polyps13 works · 0 trials
Institution data: ROR 016z2bp30 (CC0-1.0)Updated 15 Nov 2026